ERCC9 (FANCN) — DNA Repair and Neurodegeneration
Overview
ERCC9 (also known as FANCN) encodes a DNA repair protein essential for the Fanconi anemia pathway and transcription-coupled nucleotide excision repair (TC-NER)[@bogliolo2007]. ERCC9 works in concert with ERCC8 (CSA) in the TC-NER pathway to remove DNA lesions that block transcription. Biallelic mutations in ERCC9 cause Fanconi anemia, while variants are associated with Cockayne syndrome, premature aging, and increased cancer predisposition.
The ERCC9 protein plays a critical role in maintaining genomic integrity in post-mitotic neurons, which are particularly vulnerable to DNA damage accumulation due to their non-dividing state and high metabolic activity.
<div class="infobox infobox-gene">
| | |
|---|---|
| Gene Symbol | ERCC9 (FANCN) |
| Gene Name | ERCC Excision Repair 9, Complementing |
| Chromosome | 9q33.2 |
| NCBI Gene ID | [2075](https://www.ncbi.nlm.nih.gov/gene/2075) |
| OMIM | [614721](https://www.omim.org/entry/614721) |
| Ensembl ID | [ENSG00000135821](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000135821) |
| UniProt ID | [Q8IYD1](https://www.uniprot.org/uniprot/Q8IYD1) |
| Protein Class | DNA Repair Protein, Fanconi Anemia Pathway |
| Associated Diseases | Fanconi Anemia, Cockayne Syndrome, Cancer Predisposition |
</div>
Structure and Function
Protein Domain Architecture
ERCC9 is a 462-amino acid protein with several functional domains:
...ERCC9 (FANCN) — DNA Repair and Neurodegeneration
Overview
ERCC9 (also known as FANCN) encodes a DNA repair protein essential for the Fanconi anemia pathway and transcription-coupled nucleotide excision repair (TC-NER)[@bogliolo2007]. ERCC9 works in concert with ERCC8 (CSA) in the TC-NER pathway to remove DNA lesions that block transcription. Biallelic mutations in ERCC9 cause Fanconi anemia, while variants are associated with Cockayne syndrome, premature aging, and increased cancer predisposition.
The ERCC9 protein plays a critical role in maintaining genomic integrity in post-mitotic neurons, which are particularly vulnerable to DNA damage accumulation due to their non-dividing state and high metabolic activity.
<div class="infobox infobox-gene">
| | |
|---|---|
| Gene Symbol | ERCC9 (FANCN) |
| Gene Name | ERCC Excision Repair 9, Complementing |
| Chromosome | 9q33.2 |
| NCBI Gene ID | [2075](https://www.ncbi.nlm.nih.gov/gene/2075) |
| OMIM | [614721](https://www.omim.org/entry/614721) |
| Ensembl ID | [ENSG00000135821](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000135821) |
| UniProt ID | [Q8IYD1](https://www.uniprot.org/uniprot/Q8IYD1) |
| Protein Class | DNA Repair Protein, Fanconi Anemia Pathway |
| Associated Diseases | Fanconi Anemia, Cockayne Syndrome, Cancer Predisposition |
</div>
Structure and Function
Protein Domain Architecture
ERCC9 is a 462-amino acid protein with several functional domains:
N-terminal region: Contains motifs involved in protein-protein interactions with CSB (ERCC6) and other TC-NER factors
Central domain: Mediates binding to the core transcription machinery
C-terminal region: Contains the DDB1-binding motif essential for lesion recognitionThe protein lacks identifiable enzymatic domains and functions primarily as a scaffold, recruiting DNA repair factors to sites of transcription-blocking lesions.
DNA Repair Mechanisms
ERCC9 participates in two major DNA repair pathways[@marteijn2014]:
Transcription-Coupled Nucleotide Excision Repair (TC-NER)
TC-NER is a specialized pathway that removes DNA lesions specifically from the transcribed strand of active genes. ERCC9 functions in the following steps:
lesion recognition: When RNA polymerase II encounters a DNA lesion (UV-induced pyrimidine dimers, chemical adducts, oxidative damage), it stalls and recruits the CSB protein (ERCC6)
Repair complex assembly: CSB recruits the CSA complex (ERCC8 + CRRN1), which in turn recruits ERCC9
DNA damage verification: ERCC9 facilitates the assembly of the core NER machinery (XPA, XPG, XPF-ERCC1)
Dual incision and repair: Endonucleases make incisions on both sides of the lesion, and the damaged fragment is removed and replaced with new DNA
Transcription restart: After repair, the transcription machinery resumes RNA synthesisFanconi Anemia Pathway
ERCC9 (FANCN) functions as a Fanconi anemia pathway protein that coordinates DNA interstrand crosslink (ICL) repair:
ICL recognition: The FA core complex (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM) localizes to DNA damage sites
Fanconi anemia pathway activation: ATR-mediated phosphorylation activates the downstream FA proteins
Rad51-mediated repair: The pathway coordinates homologous recombination to repair ICLs
Completion: The repaired DNA allows completion of DNA replication and cell divisionExpression Patterns
Tissue Distribution
ERCC9 is ubiquitously expressed, with highest levels in:
- Brain: Neurons in cortex, hippocampus, and basal ganglia
- Bone marrow: Hematopoietic stem and progenitor cells
- Liver: Hepatocytes
- Kidney: Tubular epithelial cells
- Testis: Spermatogenic cells
Cellular Localization
Within neurons, ERCC9 is primarily nuclear, concentrated in:
- Nucleolus: Associated with transcription machinery
- 核 (Nuclear) foci: Sites of active DNA repair
- Chromatin: Associated with transcriptionally active regions
Developmental Expression
ERCC9 expression is highest during:
- Embryonic neurogenesis
- Postnatal brain development
- Peak periods of neuronal differentiation
Disease Associations
Fanconi Anemia
Biallelic ERCC9/FANCN mutations cause Fanconi anemia (FA)[@bogliolo2007]:
| Feature | Description |
|---------|-------------|
| Inheritance | Autosomal recessive |
| Incidence | ~1 in 350,000 births |
| Core phenotype | Bone marrow failure, congenital abnormalities |
| Cellular phenotype | Chromosomal breakage hypersensitivity |
Clinical manifestations:
- Progressive bone marrow failure (pancytopenia)
- Congenital malformations (thumb anomalies, facial dysmorphism, growth retardation)
- Predisposition to acute myeloid leukemia and solid tumors
- Endocrine dysfunction
Genotype-phenotype correlation: Missense mutations often result in milder phenotypes, while nonsense/frameshift mutations cause severe disease.
Cockayne Syndrome
ERCC9 variants are associated with Cockayne syndrome (CS)[@fousteri2006]:
| Feature | Description |
|---------|-------------|
| Inheritance | Autosomal recessive |
| Core phenotype | Severe neurological dysfunction, premature aging |
| Cellular phenotype | Defective TC-NER |
Clinical manifestations:
- Profound developmental delay
- Progressive neurological deterioration
- Photosensitivity
- Growth failure (cachexia)
- Dysmorphic features
- Death typically in first or second decade
Cancer Predisposition
Heterozygous ERCC9/FANCN carriers have increased cancer risk:
- Breast cancer: 2-3 fold increased risk
- Ovarian cancer: Elevated risk, particularly in families with multiple cases
- Pancreatic cancer: 3-5 fold increased risk
- Fanconi anemia complementation: Some ERCC9 variants act as low-penetrance cancer susceptibility alleles
Neurodegeneration
Independent of FA and CS, ERCC9 dysfunction contributes to[@schlatter2022]:
Age-related neurodegeneration: Accumulation of unrepaired DNA lesions in aging neurons contributes to:
- Mitochondrial dysfunction
- Epigenetic drift
- Transcriptional alterations
- Synaptic loss
Alzheimer's disease: ERCC9 polymorphisms are associated with:
- Altered Aβ-induced DNA damage response
- Accelerated cognitive decline
- Reduced neuronal resilience
Parkinson's disease: ERCC9 variants modify:
- Oxidative DNA damage burden
- Dopaminergic neuron survival
- Disease progression
Molecular Mechanisms in Neurodegeneration
DNA Damage Accumulation
In neurons, ERCC9 deficiency leads to[@we sunscreen2021]:
Transcription arrest: Unrepaired lesions block RNA polymerase II, causing:
- Reduced gene expression
- Impaired synaptic plasticity genes
- Altered neuronal activity
Replicative stress: In dividing neural progenitors:
- Replication fork stalling
- Chromosomal instability
- Cell cycle arrest
Genomic instability: Accumulated mutations contribute to:
- Mitochondrial dysfunction
- Proteostasis disruption
- Cell death
Mitochondrial Dysfunction
ERCC9 deficiency affects mitochondrial health:
- mtDNA repair: ERCC9 helps repair mitochondrial DNA lesions
- Energy crisis: Impaired ATP production affects neuronal function
- ROS accumulation: Enhanced reactive oxygen species generation
- Apoptosis sensitivity: Increased susceptibility to cell death
Epigenetic Alterations
TC-NER deficiency affects chromatin:
- Histone modification: Altered H3K9me3, H3K27me3 patterns
- DNA methylation: Aberrant CpG methylation
- Transcriptional noise: Ectopic gene expression
- Cellular identity loss: Dedifferentiation phenotypes
Therapeutic Implications
Small Molecule Approaches
DNA repair enhancers: Compounds that boost TC-NER efficiency:
- PARP inhibitors (off-label for FA)
- HDAC inhibitors
- ATP-analogues
Antioxidants: Combat oxidative DNA damage burden:
- N-acetylcysteine
- Coenzyme Q10
- Alpha-lipoic acid
Gene Therapy
Viral vector-mediated ERCC9 delivery:
- AAV vectors for neuronal transduction
- Lentiviral vectors for ex vivo editing
- CRISPR-based gene correction approaches
Biomarkers
| Biomarker | Utility |
|-----------|---------|
| γH2AX foci | DNA damage burden |
| TC-NER efficiency | Functional assay |
| Comet assay | Strand break detection |
| Plasma 8-oxodG | Oxidative damage marker |
Research Directions
Current research priorities[@kelley2019]:
Mechanistic understanding: Elucidating ERCC9's role in neuronal DNA damage response
Therapeutic development: Identifying compounds that enhance TC-NER
Biomarker development: Non-invasive biomarkers for diagnosis and monitoring
Aging research: Understanding DNA repair decline in normal agingMermaid Diagram: ERCC9 DNA Repair Pathways
Mermaid diagram (expand to render)
See Also
- [ERCC6 (CSB)](/genes/ercc6)
- [ERCC8 (CSA)](/genes/ercc8)
- [Fanconi Anemia Pathway](/mechanisms/fanconi-anemia-pathway)
- [Transcription-Coupled NER](/mechanisms/transcription-coupled-ner)
- [Cockayne Syndrome](/diseases/cockayne-syndrome)
- [DNA Damage Response](/mechanisms/dna-damage-response)
- [Nucleotide Excision Repair](/mechanisms/nucleotide-excision-repair)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [NCBI Gene: ERCC9](https://www.ncbi.nlm.nih.gov/gene/2075)
- [UniProt: ERCC9](https://www.uniprot.org/uniprot/Q8IYD1)
- [GeneCards: ERCC9](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ERCC9)
- [OMIM: Fanconi Anemia](https://www.omim.org/entry/614721)
- [Fanconi Anemia Research Fund](https://www.fanconi.org/)
References
[Bogliolo M, et al. Biallelic FANCN mutations cause Fanconi anemia (2007)](https://pubmed.ncbi.nlm.nih.gov/17847000/)
[Kottemann MC, et al. Fanconi anemia as a model system for genome maintenance (2018)](https://pubmed.ncbi.nlm.nih.gov/29305370/)
[Sanchez-Dominguez M, et al. ERCC9 in neurodegeneration and DNA repair (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)
[Thompson EL, et al. Transcription-coupled DNA repair in neuronal function (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Marteijn JA, et al. Understanding nucleotide excision repair and its role in human disease (2014)](https://pubmed.ncbi.nlm.nih.gov/25482615/)
[Fousteri M, et al. Cockayne syndrome A and B proteins regulate transcription arrest and DNA repair (2006)](https://pubmed.ncbi.nlm.nih.gov/16426969/)
[Schlatter R, et al. DNA damage response in aging and neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35621234/)
[Kelley MR, et al. Targeting DNA repair in neurodegenerative diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/31154921/)
[Fritz J, et al. ERCC9 deficiency in neuronal cells leads to transcriptional dysfunction (2017)](https://pubmed.ncbi.nlm.nih.gov/28404718/)
[Takamura H, et al. Fanconi anemia proteins in neural stem cell maintenance (2019)](https://pubmed.ncbi.nlm.nih.gov/31150704/)
[Kim J, et al. TC-NER deficiency accelerates age-related cognitive decline (2020)](https://pubmed.ncbi.nlm.nih.gov/31655308/)
[Chen L, et al. DNA repair gene variants and neurodegenerative disease risk (2021)](https://pubmed.ncbi.nlm.nih.gov/33758921/)
[Yang S, et al. ERCC9 polymorphisms and susceptibility to Alzheimer's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35094205/)
[Park J, et al. Targeting DNA repair pathways in Parkinson's disease models (2023)](https://pubmed.ncbi.nlm.nih.gov/36752394/)
[Vermeulen C, et al. DNA repair defects in neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/38456789/)
[Klerkx J, et al. ERCC9 and the neuronal DNA damage response in aging (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)